A Case Report and Literature Review of Clobazam Toxicity Related to CBD and Clobazam Drug-Drug Interaction
Journal Title: Journal of Clinical and Medical Research - Year 2019, Vol 1, Issue 2
Abstract
Background: The interest in the anti-seizure efficacy of cannabinoids has significantly increased over the past decade. Trials have shown a remarkable reduction in the frequency of convulsive seizures in Dravet and Lennox-Gastaut syndromes patient population. Studies have shown that CBD reacts with clobazam leading to a significant increase in the levels of N- desmethylclobazam, the active metabolite of clobazam. We present a case of a patient with Dravet Syndrome who presented to the ED with altered mental status secondary to clobazam toxicity related to CBD and clobazam drug-drug interaction. Methods and Findings: We present a case of a patient with Dravet Syndrome who presented to the ED with altered mental status. Patient was hospitalized and CBD was held off. Clobazam level and N-desmethylclobazam levels were obtained and came back elevated at 512 and 15020 respectively. Studies have reported clobazam toxicity secondary to CBD and clobazam drug- drug interaction since both drugs are metabolized by cytochrome P450 enzymes and glucuronyl transferases. Conclusion: Studies have shown the drug interactions of CBD with co-anti-epileptics, including a remarkable increase in the N-desmethylclobazam levels, the active metabolite of clobazam,which confirms the significant importance of monitoring blood levels for clobazam and norclobazam in patients using both CBD and clobazam, in addition for the need to reduce the Clobazam doses for this group of patients. Additional well-controlled studies are essential to establish the recommended doses and the management of the doses of other concomitant anti- epileptics medications with CBD use.
Authors and Affiliations
Rowida Kheireldin*
Keywords
Related Articles
- EP ID EP708368
- DOI https://doi.org/10.37191/Mapsci-2582-4333-1(2)-012
- Views 105
- Downloads 0
A Point of Care Lateral Flow Assay for Rapid and Colorimetric Detection of Interleukin 6 and Perspectives in Bedside Diagnostics
Interleukin-6 (IL-6) is a multifunctional cytokine and high bloodstream levels of which have been associated with severe inflammatory diseases, such as dengue fever, sepsis, various cancers, and visceral leishmaniasis (V...
Editor Note on Oral Antidiabetics Drugs: to Help Billions of Patients
Oral anti-diabetic drugs are drugs used to treat diabetes mellitus. They generally work by lowering blood sugar and their use depends on the nature of diabetes, the age and circumstances of the person, and many other fac...
A Report on COVID-19 Variants, COVID19 Vaccines and the Impact of the Variants on the Efficacy of the Vaccines
The Coronavirus pandemic has caused negative effects across the globe; mortality and morbidity being the main impact. After WHO, termed the disease a pandemic in March 2020, they gave in health guidelines to follow to co...
Building Policies for Climate Changes: Lessons from COVID-19
Aim: Global pandemics have been there since 3000 B.C. The response to pandemics has always brought with its serious consequences. In this paper, we aim to draw critical lessons derived from the recent novel COVID-19 pand...
Health-related Quality of Life among Patients with Chronic Kidney Disease of Unknown Etiology (CKDu) of an agricultural Community in Kebithigollawa, Sri Lanka
Background: The significant increase in the burden of chronic kidney disease of unknown etiology (CKDu) of Sri Lanka has led to evaluate the factors related to physical, social and mental aspects of health-related qualit...